Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix
Paton F, Paulden M, Saramago P, Manca A, Misso K, Palmer S, Eastwood A
Record ID 32013000631
English
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hta.ac.uk/erg/supplements/supplement1401.pdf#nameddest=article08
URL for additional information:
http://www.hta.ac.uk/1859
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Cost-Benefit Analysis
- Disease Progression
- Female
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Quality of Life
- Quality-Adjusted Life Years
- Treatment Outcome
- Antimetabolites, Antineoplastic
- Antineoplastic Agents, Phytogenic
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma
- Cisplatin
- Cross-Linking Reagents
- Deoxycytidine
- Drug Therapy, Combination
- Radiation-Sensitizing Agents
- Topotecan
- Uterine Cervical Neoplasms
- Vinblastine
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2010 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.